ASCO

Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications

New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection

Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction

New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes

Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

Lucence Dx Liquid Biopsy Tech Detects Structural Rearrangements, Breast Cancer Mutations

Patients Having Ovaries Removed Without Clear Genetic, Medical Rationale, Study Suggests

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests

ASCO, CAP Update HER2 Breast Cancer Testing Clinical Practice Guidelines